Cubist Systematic Strategies, LLC Chemo Centryx, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

Shares

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	SELL	$22.17 - $51.8 $988,094 - $2.31 Million	-44,569 Reduced 70.08%	19,030 $983,000
Q3 2022 Nov 14, 2022	SELL	$22.17 - $51.8 $988,094 - $2.31 Million	-44,569 Reduced 70.08%	19,030 $983,000
Q2 2022 Aug 15, 2022	BUY	$15.36 - $27.51 $477,066 - $854,433	31,059 Added 95.45%	63,599 $1.58 Million
Q1 2022 May 16, 2022	SELL	$22.22 - $39.12 $132,386 - $233,076	-5,958 Reduced 15.48%	32,540 $816,000
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $536,162 - $1.18 Million	29,171 Added 312.76%	38,498 $1.4 Million
Q3 2021 Nov 15, 2021	SELL	$13.18 - $19.83 $73,452 - $110,512	-5,573 Reduced 37.4%	9,327 $159,000
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $95,545 - $506,917	9,963 Added 201.8%	14,900 $200,000
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $169,937 - $234,680	-3,431 Reduced 41.0%	4,937 $253,000
Q4 2020 Feb 16, 2021	SELL	$47.25 - $65.16 $162,823 - $224,541	-3,446 Reduced 29.17%	8,368 $518,000
Q3 2020 Nov 16, 2020	SELL	$46.35 - $61.69 $2.4 Million - $3.19 Million	-51,686 Reduced 81.4%	11,814 $647,000
Q2 2020 Aug 14, 2020	BUY	$38.58 - $65.07 $2.28 Million - $3.85 Million	59,200 Added 1376.74%	63,500 $3.65 Million
Q1 2020 May 15, 2020	SELL	$32.73 - $50.78 $457,630 - $710,005	-13,982 Reduced 76.48%	4,300 $173,000
Q4 2019 Feb 14, 2020	SELL	$6.81 - $39.55 $57,878 - $336,135	-8,499 Reduced 31.74%	18,282 $723,000
Q3 2019 Nov 14, 2019	SELL	$6.47 - $8.96 $36,160 - $50,077	-5,589 Reduced 17.27%	26,781 $182,000
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $268,994 - $480,694	32,370 New	32,370 $301,000
Q3 2018 Nov 14, 2018	SELL	$10.49 - $13.72 $202,152 - $264,398	-19,271 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.62 - $13.98 $204,658 - $269,408	19,271 New	19,271 $254,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.